ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 18

$505K Total Retail Price of All Prescriptions

Rank: 6 out of 18

397 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

29% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 53%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $125 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 632 413 1 6
OMEPRAZOLE 377 304 2 8
SIMVASTATIN 333 210 3 4
ALLOPURINOL 310 234 4 13
TRAMADOL HCL 297 231 5 25
HYDROCODONE-ACETAMINOPHEN 278 147 S3 6 23
AMLODIPINE BESYLATE 276 205 7 5
FLUTICASONE PROPIONATE 254 191 8 19
AZITHROMYCIN 190 133 9 11
METFORMIN HCL 170 98 10 21
LEVOTHYROXINE SODIUM 168 148 11 16
PROAIR HFA 166 109 12 9
LOVASTATIN 156 128 13 12
GABAPENTIN 154 110 14 37
LOSARTAN-HYDROCHLOROTHIAZIDE 146 124 15 28
FUROSEMIDE 143 91 16 15
PREDNISONE 133 101 17 2
VENTOLIN HFA 131 76 18 18
METOPROLOL SUCCINATE 128 93 19 10
CARVEDILOL 127 95 20 59
LOSARTAN POTASSIUM 125 106 21 7
ZOLPIDEM TARTRATE 125 58 21 70
COLCRYS 116 89 23 45
CLOBETASOL PROPIONATE 112 92 24 75
CRESTOR 111 68 25 39
QVAR 97 63 26 55
NORTRIPTYLINE HCL 97 65 26 82
TAMSULOSIN HCL 96 92 28 38
SYMBICORT 90 53 29 17
FLOVENT HFA 73 26 30 56
DIOVAN 73 42 30 46
METFORMIN HCL ER 72 50 32 36
CLOPIDOGREL 71 43 33 35
GLYBURIDE 71 48 R 33 91
CIMETIDINE 68 21 35 95
ATENOLOL 66 50 36 52
PLAVIX 64 44 37 47
RANITIDINE HCL 63 60 38 53
ADVAIR DISKUS 62 52 39 1
ACETAMINOPHEN-CODEINE 62 55 S3 39 103
OXYBUTYNIN CHLORIDE 62 38 39 103
HYDROXYCHLOROQUINE SULFATE 56 45 42 110
CEPHALEXIN 55 33 43 76
HYDROXYZINE HCL 55 36 R 43 64
METOPROLOL TARTRATE 55 49 43 26
GLIPIZIDE 53 31 46 42
LANTUS SOLOSTAR 51 18 47 77
BACLOFEN 51 0 47 120
BYSTOLIC 51 29 47 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.